The ability of malignant cells to metastasize from a primary tumor and
from secondary lesions is the most life-threatening aspect of cancer.
Reported factors enabling this metastatic cascade to occur include re
duced levels or an absence of cell-adhesion molecules, prote olytic en
zymes, and angiogenic factors. The metastatic cell must also escape im
mune destruction. Defects in lymphocytes from renal-cell carcinoma pat
ients with abnormalities in their proliferation, receptor structure, a
nd signal transduction are present. The pathologic stage has been the
most consistent single prognostic factor to influence survival. Other
factors include the performance status, age, and histology grade and m
ay include serum interleukin 6 (IL-6) levels and ploidy. Current and f
uture therapeutic approaches that interfere with this metastatic casca
de include applications of cytokines, antiadhesion-molecule strategies
, and antisense nucleotides. An improvement in our understanding of th
e biology of metastases is essential before a significant increase in
the cure rate can be realized.